Most recently, we reported the relationship between Bcl-2 expression and good prognosis in RCC patients and demonstrated a significant difference in survival between Bcl-2-positive and -negative patients without metastasis (Itoi et al, 2004). Here, BCL2 is linked to renal cell adenocarcinoma.